Analyst firms · Barclays · ZBH

Barclays ZBH price target and rating history

Zimmer Biomet Holdings Inc. (ZBH) · Health Care

Barclays rates Zimmer Biomet Holdings Inc. (ZBH) Equal Weight with a $100 price target, as of its latest action on Oct 7, 2026. It has published 3 rating actions on ZBH since October 2021, including 0 upgrades and 0 downgrades. Across 6 firms with a ZBH price target in the last 12 months, the median target is $100. Barclays's target matches it.

Current rating

Equal Weight

Price target

$100

Median target, all firms

$100

Actions on ZBH

3

Barclays price target on ZBH

Every Barclays rating on ZBH

• Oct 7, 2026
  InitiateBarclays starts coverage at Equal Weight, price target $100
• Oct 18, 2022
  InitiateBarclays starts coverage at Underweight, price target $104
• Oct 5, 2021
  ReiterateBarclays cuts its price target to $186 from $210, keeps Overweight

How other firms rate ZBH

Each firm's latest rating and stated target in the last 12 months.

Questions about Barclays and ZBH

What is Barclays's price target for ZBH?

Barclays's latest stated price target for Zimmer Biomet Holdings Inc. (ZBH) is $100, from its action on Oct 7, 2026.

What is Barclays's rating on ZBH?

Barclays rates ZBH Equal Weight, a neutral rating, as of Oct 7, 2026.

When did Barclays last change its view on ZBH?

On Oct 7, 2026, Barclays starts coverage at Equal Weight, price target $100.

How does Barclays's ZBH target compare with other analysts?

Across 6 firms with a ZBH price target in the last 12 months, the median target is $100. Barclays's target matches it.

More ZBH rating histories

• UBS4
• BTIG3
• Raymond James3
• Evercore ISI4
• Piper Sandler3
• Jefferies3
• RBC Capital Markets3
• Wells Fargo3
• Needham4
• Truist Securities3
• Loop Capital3

All Barclays ratingsZBH news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.